Research & Development
Academic Report
Development of a fully automated immunoassay system of serum pembrolizumab to forecast therapeutic effectiveness
| Presented by: | Naotaka Noda1), Takuya Takahashi1), Shigehiro Yagishita2), Masahiro Miura1), Yusuke Takahashi1), Yasuhiro Irino1), Masatoshi Yanagida1), Akinobu Hamada2) 1) Central Research Laboratories, Sysmex Corporation 2) Division of Molecular Pharmacology, National Cancer Center Research Institute |
| Academic conference: | AACR Annual Meeting 2024 |
| Presentation Date: | 2024/04/10 |
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.